Teva Pharmaceuticals "pivot to growth" strategy under CEO Richard Francis aims to use a combination of biosimilars, generics, ...

Cybin CEO Doug Drysdale discusses learnings from psychedelic drug clinical trial missteps, provides examples of the benefits ...

Terns Pharmaceuticals aims to improve upon currently marketed therapies in CML and obesity, using internally discovered small ...

The Biden administration, through policy and leadership appointments, raised the level of government scrutiny over ...

Imagine a gem hunter facing a vast and uncharted landscape to uncover a single beautiful diamond. It is a bit like drug ...

No drug is free from risks, and no two human anatomies are completely identical (meaning different individuals can face different risks), but from a real-world patient perspective — anecdotally — the ...

In the world of biopharmaceutical innovation, groundbreaking scientific discoveries often do not directly translate into commercial success. Simply developing a promising therapeutic based on great ...

Approximately one in eight women in the U.S. will be diagnosed with breast cancer during their lifetime. Nearly 30 percent of women who are diagnosed with early-stage breast cancer will eventually ...

Then: In 2016, when former Life Science Leader editor Rob Wright wrote about cofounder Peter Hecht and Ironwood Pharmaceuticals, the company was ascending. After its initial launch in 1998, the ...